IA
ALDR

IFP Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

IFP Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-9
Closed – – 4171
2018
Q1 		$0 Hold
9
– – ﹤0.01% 3890
2017
Q4 		$0 Hold
9
– – ﹤0.01% 4261
2017
Q3 		$0 Hold
9
– – ﹤0.01% 4309
2017
Q2 		$0 Hold
9
– – ﹤0.01% 4309
2017
Q1 		$0 Hold
9
– – ﹤0.01% 4232
2016
Q4 		$0 Hold
9
– – ﹤0.01% 4221
2016
Q3 		$0 Buy
+9
New +$274 ﹤0.01% 4137
2016
Q1 		– Sell
-28
Closed -$1K – 3813
2015
Q4 		$1K Buy
+28
New +$947 ﹤0.01% 3626

Other funds holding ALDR

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

IFP Advisors's ALDR Position: Q2 2018 in Review

IFP Advisors sold out of Alder Biopharmaceuticals (ALDR) in Q2 2018, closing a stake of 9 shares.

IFP Advisors first reported a position in ALDR in Q4 2015 and held it in 8 quarters. The position peaked at $1K in Q4 2015. 139 funds tracked by Wall St. Rank hold ALDR as of Q2 2018.

  • IFP Advisors reported no remaining Alder Biopharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • IFP Advisors sold 9 Alder Biopharmaceuticals shares in Q2 2018.
  • IFP Advisors first reported a position in Alder Biopharmaceuticals in Q4 2015 and held it in 8 quarters.
  • IFP Advisors's Alder Biopharmaceuticals position peaked at $1K in Q4 2015.
  • 139 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2018.

Based on IFP Advisors's 13F filing for Q2 2018, filed 7 Aug 2018.